China Life Insurance (SEHK:2628) Q3 Results Confront A Sharp Earnings Reversal

China Life Insurance closed at HK$23.88 on 30 October, after a choppy month that left the stock down about 15% over 30 days and roughly 18% over three months. Against that muted backdrop, the Q3 2026 report landed with a jolt as the insurer swung to a quarterly net loss of ¥45,059m and a basic loss per share of ¥1.59. Short-term traders may fixate on that hit. Long-horizon investors are more likely to weigh it against the still-profitable trailing twelve months and a P/E that sits below both industry and peer averages.

Like the valuation but uneasy about a fresh quarterly loss at China Life Insurance? Check out the list of solid balance sheet and fundamentals stocks (200 results).

Q3 2026 Earnings Summary

• Total Revenue (Q3 2026 vs Q3 2025): loss of ¥30,185m vs. revenue of ¥173,651m (swing from positive revenue to a reported revenue loss)
• Net Income / Loss (Q3 2026 vs Q3 2025): net loss of ¥45,059m vs. net profit of ¥126,873m (moved from profit to loss)
• Basic EPS (Q3 2026 vs Q3 2025): loss per share of ¥1.59 vs. earnings per share of ¥4.50 (shifted from earnings to a per share loss)
• Trailing 12-Month Net Income (Q3 2026 TTM vs Q3 2025 TTM): ¥75,704m vs. ¥170,216m (lower trailing profit compared with the prior 12 months)

China Life Insurance flipped from strong profits to a quarterly loss. Ask Charlie what drove China Life Insurance’s profit swing this year.

China Life bullish mix shift meets profit reality

Optimists argue that China Life Insurance can lean on richer products and a more productive sales force to lift earnings quality.

"China Life Insurance is putting more weight on higher margin products, supported by a 75.5% increase in value of new business in Q1 2026, which is expected to feed through to revenue quality and net margins as those policies earn out."

The latest quarter shows the stress test. A reported revenue loss of ¥30,185m and net loss of ¥45,059m sit awkwardly beside that VONB story. Trailing 12 month profit of ¥75,704m still exists, yet the near term margin hit suggests the mix shift is not offsetting investment and earnings volatility so far.

Bear case on earnings quality gains more traction

Skeptics worry that headline growth in new policies at China Life masks weaker underlying profitability and choppy investment returns.

"If the rapid increase in the value of new business does not feed through to higher quality earnings, for example because operating income and return on equity remain under pressure as seen in Q1 2026, the expected improvement in net margins and overall earnings may not materialise."

Q3 2026 gives that concern more weight. The swing from a prior year profit to a ¥45,059m loss, alongside a move from positive revenue to a reported revenue loss, signals exactly the earnings translation risk bears highlight.

One Narrative disagrees with today's price. → See where this Narrative says China Life Insurance should trade.

Hunt For Mispriced Cash Generators

China Life Insurance shows how a single quarter can reshape an earnings narrative. The real opportunity is in spotting potentially undervalued businesses before the market reassesses them.

• Company 1 - 43% below our estimate - uses a rebuilt cloud stack and AI assisted coding to release savings and SME banking tools more quickly.
• Company 2 - 21% below our estimate - adds an aviation data acquisition to convert electronics backlog into higher margin aftermarket contracts.
• Company 3 - 46% below our estimate - turns a large construction backlog and several mega projects into trials for tighter execution and faster cash collection.

Those are three of them. See the full list of 194 companies trading below our fair value estimates →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com